Ovarian Cancer | Tumor

CURE’s ovarian cancer page is a go-to resource for oncology news and updates in the world of ovarian cancer Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in ovarian cancer.

Identifying Genetic Similarities in Tumors May Shed Light on Spread of Ovarian Cancer

March 26th 2019, 3:00pm

Article

Researchers define the genetic characteristics of ovarian tumors-- information that could lead to new opportunities for personalized therapy and may explain why screening programs for the disease haven’t been successful.

Reflections on Life After Two Prophylactic Surgeries

March 24th 2019, 4:00pm

Article

Ten years later, a woman with a BRCA1 mutation finally feels more like herself.

Primary Peritoneal Cancer: Know the Basics

March 22nd 2019, 6:24pm

Article

Understand how the rare relative of ovarian cancer is diagnosed and treated.

Ovarian Cancer Screening Tool Should be a Top Research Priority

March 21st 2019, 6:07pm

Article

Did we bring this scary, painful, financially draining monster into our lives by eating too many cookies and not doing enough jumping jacks? We need a reliable diagnostic screening tool for ovarian cancer and we need it now.

'Stopping to Smell the Roses' With Olympic Gymnast Shannon Miller

March 21st 2019, 5:00pm

Podcast

In this week’s episode, we spoke with the most decorated Olympic gymnast and ovarian cancer survivor Shannon Miller before CURE’s second annual Ovarian Cancer Heroes gala.

Lenvima Prompts Durable Responses in Ovarian, Endometrial Cancers

March 20th 2019, 8:00pm

Article

Lenvima (lenvatinib) in combination with weekly paclitaxel induced activity among those with recurrent endometrial and platinum-resistant epithelial ovarian cancer, according to results from a phase I study.

Triplet Combo Yields Durable Responses in Recurrent Epithelial Ovarian Cancer

March 19th 2019, 7:00pm

Article

Treatment with the combination of Keytruda (pembrolizumab), Avastin (bevacizumab) and metronomic cyclophosphamide appeared safe and effective in women with recurrent epithelial ovarian cancer, according to results from an open-label phase 2 study.

Initial PARP Inhibitor Use for Ovarian Cancer May Not Lead to Resistance in Secondary Use

March 18th 2019, 6:37pm

Article

Prior exposure to PARP inhibitor treatment may not lead to resistance in future use with these agents in women with recurrent epithelial ovarian cancer, meaning repeat use could become more common.

Individualized Dosing Regimen Reduces Side Effects in Ovarian Cancer Maintenance Therapy

March 18th 2019, 6:26pm

Article

Side effects decreased among patients with high-risk ovarian cancer who received an individualized starting dose of Zejula (niraparib), based upon baseline bodyweight and platelet counts, compared with a fixed starting dose.

Zejula Maintenance Therapy Extends Symptom-Free Survival in Recurrent Ovarian Cancer

March 17th 2019, 4:00pm

Article

Patients with recurrent ovarian cancer who received Zejula (niraparib) maintenance therapy experienced longer progression-free survival, as well as more time without symptoms or toxicity compared with placebo, according to results from the phase 3 ENGOT-OV16/NOVA trial.